State Street Corp Amgen Inc Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Amgen Inc stock. As of the latest transaction made, State Street Corp holds 29,317,018 shares of AMGN stock, worth $8.44 Billion. This represents 0.39% of its overall portfolio holdings.

Number of Shares

29,317,018

Previous 28,971,481 1.19%

Holding current value

$8.44 Billion

Previous $9.05 Billion 4.35%

% of portfolio

0.39%

Previous 0.4%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$309.38 - $337.38 $107 Million - $117 Million	345,537 Added 1.19%	29,317,018 $9.45 Billion
Q2 2024 Aug 14, 2024	SELL	$262.75 - $319.31 $42.3 Million - $51.4 Million	-160,831 Reduced 0.55%	28,971,481 $9.05 Billion
Q1 2024 May 15, 2024	SELL	$268.87 - $324.56 $89.2 Million - $108 Million	-331,658 Reduced 1.13%	29,132,312 $8.28 Billion
Q4 2023 Feb 14, 2024	BUY	$255.7 - $288.46 $227 Million - $256 Million	888,483 Added 3.11%	29,463,970 $8.49 Billion
Q3 2023 Nov 14, 2023	SELL	$218.65 - $271.46 $114 Million - $142 Million	-523,394 Reduced 1.8%	28,575,487 $7.68 Billion
Q2 2023 Aug 14, 2023	SELL	$214.27 - $253.37 $14.6 Million - $17.3 Million	-68,251 Reduced 0.23%	29,098,881 $6.46 Billion
Q1 2023 May 15, 2023	SELL	$225.79 - $275.2 $116 Million - $141 Million	-511,955 Reduced 1.72%	29,167,132 $7.05 Billion
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $139 Million - $176 Million	606,026 Added 2.08%	29,679,087 $7.79 Billion
Q3 2022 Nov 15, 2022	SELL	$224.46 - $253.15 $46.7 Million - $52.6 Million	-207,866 Reduced 0.71%	29,073,061 $6.55 Billion
Q2 2022 Aug 15, 2022	SELL	$230.71 - $256.74 $282 Million - $314 Million	-1,223,493 Reduced 4.01%	29,280,927 $7.12 Billion
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $78.4 Million - $86.7 Million	357,413 Added 1.19%	30,504,420 $7.38 Billion
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $100 Million - $115 Million	505,306 Added 1.7%	30,147,007 $6.78 Billion
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $61.5 Million - $72 Million	-289,680 Reduced 0.97%	29,641,701 $6.3 Billion
Q2 2021 Aug 16, 2021	BUY	$233.58 - $259.14 $55.7 Million - $61.8 Million	238,297 Added 0.8%	29,931,381 $7.3 Billion
Q1 2021 May 17, 2021	SELL	$221.91 - $258.6 $88.8 Million - $103 Million	-400,052 Reduced 1.33%	29,693,084 $7.39 Billion
Q4 2020 Feb 16, 2021	SELL	$216.38 - $257.67 $257 Million - $306 Million	-1,185,863 Reduced 3.79%	30,093,136 $6.92 Billion
Q3 2020 Nov 10, 2020	BUY	$234.65 - $260.95 $1.18 Billion - $1.31 Billion	5,016,641 Added 19.1%	31,278,999 $7.95 Billion
Q2 2020 Aug 14, 2020	BUY	$197.81 - $242.74 $11 Million - $13.4 Million	55,408 Added 0.21%	26,262,358 $6.19 Billion
Q1 2020 May 11, 2020	BUY	$182.24 - $241.7 $4.78 Billion - $6.33 Billion	26,206,950 New	26,206,950 $5.31 Billion

Others Institutions Holding AMGN

# of Institutions

3,121

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $154B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Amgen Inc Transaction History